We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gilead Grants Remdesivir Licenses to Four More Generic Drugmakers
Gilead Grants Remdesivir Licenses to Four More Generic Drugmakers
Gilead Sciences has signed four more non-exclusive licensing agreements with generic drugmakers to make remdesivir available to COVID-19 patients in low-income countries.